Skip to Main Content

Paper Details

Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.
Am Heart J
6
2022
Author NameAffiliation
Rishi J DesaiDivision of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Sebastian SchneeweissDivision of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Elisabetta PatornoDivision of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2